In vitro effect of the iron chelator deferiprone on the antimicrobial susceptibility and biofilms of Burkholderia pseudomallei

Biofouling. 2023 Feb;39(2):135-144. doi: 10.1080/08927014.2023.2192405. Epub 2023 Apr 4.

Abstract

This study evaluated the effect of the iron chelator deferiprone (DFP) on antimicrobial susceptibility and biofilm formation and maintenance by Burkholderia pseudomallei. Planktonic susceptibility to DFP alone and in combination with antibiotics was evaluated by broth microdilution and biofilm metabolic activity was determined with resazurin. DFP minimum inhibitory concentration (MIC) range was 4-64 µg/mL and in combination reduced the MIC for amoxicillin/clavulanate and meropenem. DFP reduced the biomass of biofilms by 21 and 12% at MIC and MIC/2, respectively. As for mature biofilms, DFP reduced the biomass by 47%, 59%, 52% and 30% at 512, 256, 128 and 64 µg/mL, respectively, but did not affect B. pseudomallei biofilm viability nor increased biofilm susceptibility to amoxicillin/clavulanate, meropenem and doxycycline. DFP inhibits planktonic growth and potentiates the effect of β-lactams against B. pseudomallei in the planktonic state and reduces biofilm formation and the biomass of B. pseudomallei biofilms.

Keywords: Burkholderia pseudomallei; biofilms; deferiprone; iron chelator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Burkholderia pseudomallei*
  • Deferiprone / pharmacology
  • Iron / metabolism
  • Iron / pharmacology
  • Iron Chelating Agents / pharmacology
  • Meropenem / pharmacology
  • Microbial Sensitivity Tests

Substances

  • Meropenem
  • Deferiprone
  • Iron
  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination
  • Iron Chelating Agents